Pneumococcal 24-Valent Conjugate Vaccine（Tianjin Cansino Biotech）
24价肺炎球菌多糖结合疫苗（康希诺生物）
Report date: 2026/05/25 20:02:40
Base Information
Drug NamePneumococcal 24-Valent Conjugate Vaccine（Tianjin Cansino Biotech）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesTianjin Cansino Biotechnology Inc
China Registration ClassN/A
Develop Information
Active CompaniesKangxinuo (Shanghai) Biotechnology Co LtdCanSino Biologics IncTianjin Cansino Biotechnology Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A